Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease
https://doi.org/10.15829/1728-8800-2011-4-63-68
Abstract
Aim. In a non-randomised study, to assess middle-term (9 months) effectiveness and safety of percutaneous coronary intervention (PCI) with “Ephesos II” stent implantation.
Material and methods. The study included 41 patients, treated at the Sani Konukoglu Medical Centre, Gaziantep, Turkey.
Results. Immediate angiography-confirmed PCI success was achieved in 100 % of the participants. Nine months after the intervention, the percentage of survived patients without restenosis and repeat revascularization was 77,6 %. Control angiography at 9 months was performed in 95,1 % of the patients. The mean in-stent late loss was 0,32±0,25. Restenosis was observed in 22,4 % of the subjects. In all cases of in-stent restenosis, successful repeat PCI was performed. At 9 months, the proportion of the survived patients without moderate to severe cardiac complications and events reached 70,3 %.
Conclusion. This non-randomised study demonstrated good short and middle-term results of PCI with standard metallic stent “Ephesos II” implantation.
About the Authors
T. A. Batyraliev
Sani Konukoglu Medical Centre
Turkey
Gaziantep
Turkey
Gaziantep
D. V. Fetzer
Областная клиническая больница г.Липецка
Russian Federation
Russian Federation
D. V. Preobrazhenskyi
RF President’s Administration Medical Centre
Russian Federation
Moscow
Russian Federation
Moscow
A. Kochak
Sani Konukoglu Medical Centre
Turkey
Gaziantep
Turkey
Gaziantep
Yu. N. Belenkov
M.V. Lomonosov Moscow State University
Russian Federation
Russian Federation
References
1. Uyan С, Akdemir R, Gunduz H, et al. Immediate and six months clinical and angiographic results of intracoronary Ephesos stent implantation: the ”Ephesos-1” study. Acta Cordial 2005; 60(1): 185-90.
2. Беленков Ю.Н., Самко А.Н., Батыралиев Т.А. и др. Двухлетние результаты после имплантации металлического стента “Ephesos” у пациентов с коронарной болезнью. Тер архив 2005; 9: 49-52.
3. Pershukov I, Batyraliev T, Samko A, et al. Results of ”Ephesos” coronary stent implantation in patients with unstable or stable angina. Eur J Gen Med 2004; 1: 19-25.
4. Батыралиев Т.А., Самко А.Н., Першуков И.В. и др. Клинические и ангиографические результаты применения стента Ephesos у больных атеросклерозом коронарных артерий. Кардиология 2002; 2: 4-7.
5. King SB, Aversano T, Ballard WL, et al. ACCF/AHA/SCAI 2007 Update of the Clinical Competence Statement on Cardiac Interventional Procedures. Circulation 2007; 116: 98-124.
6. Balcon R, Beyar R, Chierchia S, et al. for the Study Group of the Working Group on Coronary Circulation. Recommendations on stent manufacture, implantation and utilization. Eur Heart J 1997; 18: 1536-47.
7. Eeckhout E, Wijns W, Meier B, Goy JJ on behalf of the members of the Working Group on Coronary Circulation of the European Society of Cardiology. Indications for coronary stent placement: the European view. Eur Heart J 1999; 20: 1014-9.
8. Serruys PW, Kutryk MJB. Handbook of coronary stents. Third edition. Martin Dunitz 2000; p.424.
9. Бабунашвили А.М., Иванов В.А., Бирюков С.А. Эндопротезирование (стентирование) венечных артерий сердца. Издательство АСВ, Москва 2000; 704 с.
10. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701-6.
11. Батыралиев Т.А., Фетцер Д.В., Преображенский Д.В., Сидоренко Б.А. Проблема осложнений при чрескожных коронарных вмешательствах. Часть I. Характер и частота осложнений. Кардиология 2008; 48(1): 81-7.
12. Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 1988; 78: 1121-7.
13. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med 1994; 331: 489-95.
14. Baim DS, Levine MJ, Leon MB, et al. Management of restenosis within the Palmaz-Schatz coronary stent: the U.S. multicenter experience — the U.S. Palmaz-Schatz Stent Investigators. Am J Cardiol 1993; 71: 364-6.
15. Antoniucci D, Bartorelli A, Valenti R, et al. Clinical and Angiographic Outcome After Coronary Arterial Stenting With the Carbostent. Am J Cardiol 2000; 85: 821-5.
16. Boland JL, Corbeij HAM, Van Der Giessen W, et al. Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Intervent 2000; 3: 215-25.
17. Батыралиев Т.А., Першуков И.В. Обзор клинических исследований по ишемической болезни сердца и ее инвазивному лечению. Кардиология 2002; 5: 68-70.
18. Rensing BJ, Vos J, Smits PC, et al. Coronary restenosis elimination with a sirolimus eluting stent. First European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 2001; 22: 2125-30.
19. Беленков Ю.Н., Батыралиев Т.А., Першуков И.В., Самко А.Н. Инвазивная кардиология — фокус на рестеноз. Часть II. Кардиология 2002; 11: 68-72.
20. Жамгыргиев Ш.Т., Фетцер Д.В., Першуков И.В. и др. Клиническое значение стентов с лекарственным покрытием. Тер архив 2007; 9: 79-84.
21. Zidar JP, Fry E, Lambert C, et al. The VENUS trial: A multicenter registry of the Cordis BX Velocity stent. Am J Cardiol 2000; 86: suppl.8A: 17i.
22. Boland JL, Corbeij HAM, Van Der Giessen W, et al. Multicenter evaluation of the phosphorylcholinecoated Biodivysio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Intervent 2000; 3: 215-25.
23. Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory response and arterial injury to neointimal hyperplasia. JACC 1998; 31: 224-30.
24. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995; 91: 2995-3001.
25. Serruys PW, van Hout B, Bonnier H, et al. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673-81.
Review
For citations:
Batyraliev T.A., Fetzer D.V., Preobrazhenskyi D.V., Kochak A., Belenkov Yu.N. Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease. Cardiovascular Therapy and Prevention. 2011;10(4):63-68. (In Russ.) https://doi.org/10.15829/1728-8800-2011-4-63-68
Views:
492
Email this article 
